💊
İlaç Sektörü Hisseleri
İlaç Sektörü altında 513 Hisse Senedi
İlaç sektöründe faaliyet gösteren ABD şirketlerinin hisse senetleri. Gerçek zamanlı fiyatlar, finansal analizler ve detaylı şirket bilgileri.
100
Toplam Hisse
$30.3B
Toplam Piyasa Değeri
İlaç Sektörü Hisseleri
Sayfa 3/6 (Toplam: 513)
| SEMBOL | ŞİRKET | PİYASA DEĞERİ | FİYAT | DEĞİŞİM |
|---|---|---|---|---|
| CGEM | Cullinan Oncology, Inc. | $478.61M | $8.11 | 7.85% |
| ERAS | Erasca, Inc. | $475.92M | $1.68 | 12.00% |
| LFMD | LifeMD, Inc. | $470.84M | $10.36 | 0.58% |
| RZLT | Rezolute, Inc. | $467.17M | $5.37 | 0.19% |
| ATYR | aTyr Pharma, Inc. | $466.38M | $5.24 | 8.23% |
| ABSI | Absci Corporation | $463.04M | $3.63 | 3.42% |
| SRDX | Surmodics, Inc. | $456.22M | $31.91 | 2.36% |
| PGEN | Precigen, Inc. | $448.67M | $1.52 | 16.94% |
| PRTC | PureTech Health plc | $445.67M | $18.55 | 5.68% |
| LXRX | Lexicon Pharmaceuticals, Inc. | $435.81M | $1.20 | 2.44% |
| RGNX | REGENXBIO Inc. | $431.83M | $8.57 | 0.94% |
| CMPX | Compass Therapeutics, Inc. | $424.53M | $3.07 | 0.00% |
| NKTR | Nektar Therapeutics | $423.53M | $24.48 | 1.25% |
| AURA | Aura Biosciences, Inc. | $419.77M | $6.77 | 0.00% |
| SVRA | Savara Inc. | $416.54M | $2.41 | 5.24% |
| TECX | Tectonic Therapeutic, Inc. | $414.90M | $22.22 | 1.37% |
| AQST | Aquestive Therapeutics, Inc. | $394.33M | $3.97 | 6.15% |
| ARCT | Arcturus Therapeutics Holdings Inc. | $394.06M | $14.53 | 5.37% |
| MBX | MBX Biosciences, Inc. Common Stock | $391.07M | $11.70 | 4.02% |
| GOSS | Gossamer Bio, Inc. | $390.96M | $1.72 | 1.71% |
| EBS | Emergent BioSolutions Inc. | $388.63M | $7.16 | 3.17% |
| ITOS | iTeos Therapeutics, Inc. | $387.33M | $10.12 | 0.10% |
| VIGL | Vigil Neuroscience, Inc. | $384.35M | $8.06 | 0.25% |
| FULC | Fulcrum Therapeutics, Inc. | $380.55M | $7.05 | 0.70% |
| CTMX | CytomX Therapeutics, Inc. | $376.53M | $2.39 | 0.42% |
| CYRX | Cryoport, Inc. | $372.52M | $7.43 | 10.73% |
| RCKT | Rocket Pharmaceuticals, Inc. | $363.08M | $3.37 | 7.67% |
| RIGL | Rigel Pharmaceuticals, Inc. | $358.52M | $20.06 | 2.40% |
| HUMA | Humacyte, Inc. | $356.77M | $2.30 | 0.00% |
| FHTX | Foghorn Therapeutics Inc. | $353.40M | $6.34 | 3.93% |
| GLUE | Monte Rosa Therapeutics, Inc. | $348.15M | $5.66 | 2.92% |
| ALMS | Alumis Inc. Common Stock | $341.56M | $3.31 | 0.30% |
| ALT | Altimmune, Inc. | $340.65M | $4.20 | 3.70% |
| CRVS | Corvus Pharmaceuticals, Inc. | $333.91M | $4.33 | 2.70% |
| ABEO | Abeona Therapeutics Inc. | $333.54M | $6.52 | 3.41% |
| INBX | Inhibrx Biosciences, Inc. | $330.92M | $22.86 | 3.35% |
| TNXP | Tonix Pharmaceuticals Holding Corp. | $329.23M | $44.75 | 0.78% |
| TOI | The Oncology Institute, Inc. | $325.37M | $3.54 | 3.81% |
| ALDX | Aldeyra Therapeutics, Inc. | $321.04M | $5.36 | 0.56% |
| CATX | Perspective Therapeutics, Inc. | $319.18M | $4.30 | 0.23% |
| RNAC | Cartesian Therapeutics, Inc. | $316.12M | $12.18 | 1.08% |
| VREX | Varex Imaging Corporation | $314.57M | $7.58 | 2.36% |
| NGNE | Neurogene Inc. | $312.91M | $21.94 | 1.29% |
| OLMA | Olema Pharmaceuticals, Inc. | $310.63M | $4.54 | 1.09% |
| ALLO | Allogene Therapeutics, Inc. | $310.60M | $1.42 | 7.58% |
| NMRA | Neumora Therapeutics, Inc. Common Stock | $305.70M | $1.89 | 3.57% |
| XOMA | XOMA Corporation | $304.56M | $25.45 | 0.12% |
| OCGN | Ocugen, Inc. | $300.79M | $1.03 | 1.98% |
| CAPR | Capricor Therapeutics, Inc. | $298.01M | $6.52 | 3.99% |
| BNTC | Benitec Biopharma Inc. | $295.58M | $11.26 | 0.72% |
| SGMT | Sagimet Biosciences Inc. | $294.48M | $9.60 | 8.72% |
| KOD | Kodiak Sciences Inc. | $294.42M | $5.58 | 9.84% |
| AVIR | Atea Pharmaceuticals, Inc. | $293.54M | $3.43 | 0.00% |
| HRTX | Heron Therapeutics, Inc. | $289.87M | $1.90 | 1.04% |
| VSTM | Verastem, Inc. | $289.58M | $5.27 | 3.33% |
| GBIO | Generation Bio Co. | $286.24M | $4.27 | 1.43% |
| SCPH | scPharmaceuticals Inc. | $284.02M | $5.38 | 4.87% |
| VNDA | Vanda Pharmaceuticals Inc. | $277.58M | $4.71 | 1.07% |
| MNPR | Monopar Therapeutics Inc. | $276.53M | $45.22 | 2.61% |
| LFCR | Lifecore Biomedical, Inc. | $275.47M | $7.44 | 0.27% |
| TSVT | 2seventy bio, Inc. | $266.14M | $5.00 | 0.00% |
| SLP | Simulations Plus, Inc. | $262.25M | $13.04 | 0.76% |
| ANNX | Annexon, Inc. | $260.02M | $2.37 | 4.05% |
| INZY | Inozyme Pharma, Inc. | $258.25M | $4.00 | 0.25% |
| VMD | Viemed Healthcare, Inc. | $256.90M | $6.50 | 0.46% |
| VOR | Vor Biopharma Inc. | $256.17M | $2.05 | 0.24% |
| CDXS | Codexis, Inc. | $252.68M | $3.05 | 7.58% |
| OABI | OmniAb, Inc. | $249.29M | $2.06 | 4.04% |
| OPRX | OptimizeRx Corporation | $245.98M | $13.30 | 3.26% |
| THRD | Third Harmonic Bio, Inc. | $245.04M | $5.43 | 0.00% |
| TRDA | Entrada Therapeutics, Inc. | $242.14M | $6.38 | 3.91% |
| ESPR | Esperion Therapeutics, Inc. | $241.80M | $1.22 | 6.09% |
| DSGN | Design Therapeutics, Inc. | $241.27M | $4.25 | 4.94% |
| MXCT | MaxCyte, Inc. | $238.15M | $2.24 | 6.67% |
| SLRN | Acelyrin, Inc. | $229.17M | $2.27 | 0.00% |
| ELDN | Eledon Pharmaceuticals, Inc. | $222.16M | $3.71 | 0.54% |
| OMER | Omeros Corporation | $219.14M | $3.74 | 2.75% |
| VRNOF | Verano Holdings Corp. | $218.67M | $0.61 | 3.03% |
| LCTX | Lineage Cell Therapeutics, Inc. | $216.94M | $0.95 | 0.60% |
| LRMR | Larimar Therapeutics, Inc. | $216.41M | $3.38 | 3.68% |
| REPL | Replimune Group, Inc. | $216.23M | $2.81 | 77.24% |
| VTYX | Ventyx Biosciences, Inc. | $214.91M | $3.02 | 2.37% |
| FDMT | 4D Molecular Therapeutics, Inc. | $208.46M | $4.50 | 6.13% |
| CRGX | CARGO Therapeutics, Inc. Common Stock | $207.05M | $4.49 | 0.66% |
| TVGN | Tevogen Bio Holdings Inc. | $206.12M | $1.11 | 3.48% |
| RAPT | RAPT Therapeutics, Inc. | $203.06M | $12.28 | 4.96% |
| YMAB | Y-mAbs Therapeutics, Inc. | $199.75M | $4.41 | 1.85% |
| DRUG | Bright Minds Biosciences Inc. | $187.10M | $26.41 | 1.05% |
| TIL | Instil Bio, Inc. | $186.56M | $28.44 | 2.97% |
| SLS | SELLAS Life Sciences Group, Inc. | $183.59M | $1.84 | 0.54% |
| UTMD | Utah Medical Products, Inc. | $183.33M | $56.44 | 1.60% |
| GALT | Galectin Therapeutics Inc. | $181.01M | $2.86 | 4.38% |
| KYTX | Kyverna Therapeutics, Inc. | $177.20M | $4.10 | 5.94% |
| ACRS | Aclaris Therapeutics, Inc. | $175.42M | $1.62 | 1.22% |
| VYGR | Voyager Therapeutics, Inc. | $174.86M | $3.16 | 0.32% |
| PBYI | Puma Biotechnology, Inc. | $172.24M | $3.47 | 1.76% |
| ALEC | Alector, Inc. | $171.99M | $1.72 | 6.17% |
| TLSI | TriSalus Life Sciences, Inc. | $170.89M | $4.50 | 1.53% |
| ISPR | Ispire Technology Inc. | $170.86M | $2.99 | 0.33% |
| BIOA | BioAge Labs, Inc. | $170.65M | $4.76 | 3.48% |